TITLE

A 4-month-old in respiratory distress

AUTHOR(S)
MULLAN, PAUL; STEENHOFF, ANDREW; RUTSTEIN, RICHARD
PUB. DATE
October 2009
SOURCE
Contemporary Pediatrics;Oct2009, Vol. 26 Issue 10, p26
SOURCE TYPE
Periodical
DOC. TYPE
Case Study
ABSTRACT
The article describes the case of a 4-month-old infant girl who was diagnosed with HIV. The patient experienced various symptoms, including cough, rapid breathing, jaundice and white stools. The infant was subjected to highly active antiretroviral therapy (HAART) with zidovudine, lopinavir/ritonavir, and lamivudine.
ACCESSION #
44843949

 

Related Articles

  • Pharmacokinetics of Antiretroviral Drug Varies With Formulation in the Target Population of Children With HIV-1. Kasirye, P; Kendall, L; Adkison, K K; Tumusiime, C; Ssenyonga, M; Bakeera-Kitaka, S; Nahirya-Ntege, P; Mhute, T; Kekitiinwa, A; Snowden, W; Burger, D M; Gibb, D M; Walker, A S // Clinical Pharmacology & Therapeutics;Feb2012, Vol. 91 Issue 2, p272 

    The bioequivalence of formulations is usually evaluated in healthy adult volunteers. In our study in 19 HIV-1-infected Ugandan children (1.8-4 years of age, weight 12 to <15 kg) receiving zidovudine, lamivudine, and abacavir solutions twice a day for ≥24 weeks, the use of scored tablets...

  • Cardiometabolic risk factors among HIV patients on antiretroviral therapy. Kiage, James N.; Heimburger, Douglas C.; Nyirenda, Christopher K.; Wellons, Melissa F.; Bagchi, Shashwatee; Chi, Benjamin H.; Koethe, John R.; Arnett, Donna K.; Kabagambe, Edmond K. // Lipids in Health & Disease;2013, Vol. 12 Issue 1, p1 

    Background: HIV and combination antiretroviral therapy (cART) may increase cardiovascular disease (CVD) risk. We assessed the early effects of cART on CVD risk markers in a population with presumed low CVD risk. Methods: Adult patients (n=118) in Lusaka, Zambia were recruited at the time of...

  • Maraviroc versus Efavirenz, Both in Combination with Zidovudine-Lamivudine, for the Treatment of Antiretroviral-Naive Subjects with CCR5-Tropic HIV-1 Infection. Cooper, David A.; Heera, Jayvant; Goodrich, James; Tawadrous, Margaret; Saag, Michael; DeJesus, Edwin; Clumeck, Nathan; Walmsley, Sharon; Ting, Naitee; Coakley, Eoin; Reeves, Jacqueline D.; Reyes-Teran, Gustavo; Westby, Mike; Van Der Ryst, Elna; Ive, Prudence; Mohapi, Lerato; Mingrone, Horacio; Horban, Andrzej; Hackman, Frances; Sullivan, John // Journal of Infectious Diseases;3/15/2010, Vol. 201 Issue 6, p803 

    Background. The MERIT (Maraviroc versus Efavirenz in Treatment-Naive Patients) study compared maraviroc and efavirenz, both with zidovudine-lamivudine, in antiretroviral-naive patients with R5 human immunodeficiency virus type 1 (HIV-1) infection. Methods. Patients screened for R5 HIV-1 were...

  • Antiretrovirals.  // Reactions Weekly;5/10/2008, Issue 1201, p8 

    The article describes the case of eighteen patients in the ASCENT study or EPIC study with HIV infection developed hepatotoxicity during treatment with antiretrovirals. Patients in the ASCENT study were receiving aplaviroc, zidovudine and lamivudine twice daily and those in the EPIC study were...

  • Aminotransferase Serum Levels Decrease after Initiating Antiretroviral Treatment in HIV Infected Patients. Mata-Marín, José Antonio; Martínez, Jesús Gaytán; Flores, Rafael Arias; Álvarez, Sergio Mendoza; de Jesús Asencio Montiel, Iván // Current HIV Research;Jan2011, Vol. 9 Issue 1, p23 

    No abstract available.

  • Adverse Reactions Associated with Antiretroviral Regimens in Adult Patients of a University Teaching Hospital HIV Program in Zaria, Northern Nigeria: An Observational Cohort Study. Reginald, Obiako O.; Haruna, Muktar M.; Sani, Garko B.; Eric, Tobi-Ajayi; Adebola, Olayinka T.; Mathew, Iyanda; Chigozie, Irohibe; Bilkisu, Umar; Ibrahim, Abdu-Aguye // Journal of Antivirals & Antiretrovirals;2012, Vol. 4 Issue 1, p6 

    Background: Highly active antiretroviral therapy (HAART) has reduced the morbidity associated with HIV infection, and prolonged the lifespan of HIV/AIDS patients, but reports of adverse reactions associated with the antiretroviral drugs exist in the literature. The aim of this research was to...

  • The impact of zidovudine on dementia-free survival in a population of HIV-positive men and women on antiretroviral therapy. Cornelisse, Peter G. A.; Montessori, Val; Yip, Benita; Craib, Kevin J. P.; O'Shaughnessy, Michael V.; Montaner, Julio S. G.; Hogg, Robert S.; Cornelisse, P G; Montessori, V; Yip, B; Craib, K J; O'Shaughnessy, M V; Montaner, J S; Hogg, R S // International Journal of STD & AIDS;Jan2000, Vol. 11 Issue 1, p52 

    Our objective was to characterize the effect of zidovudine therapy on AIDS dementia complex (dementia) free survival among HIV-infected men and women in a population-based cohort with free access to antiretroviral therapy in the province of British Columbia. Time to diagnosis of dementia among...

  • Combination therapy for HIV: the effect on inpatient activity, morbidity and mortality of a cohort of patients. Brettle, Ray P.; Wilson, Alan; Povey, Sarah; Morris, Sheila; Morgan, Rhoda; Leen, Clifford L. S.; Hutchinson, Sharon; Lewis, Steff; Gore, Sheila; Brettle, R P; Wilson, A; Povey, S; Morris, S; Morgan, R; Leen, C L; Hutchinson, S; Lewis, S; Gore, S // International Journal of STD & AIDS;Feb1998, Vol. 9 Issue 2, p80 

    We set out to quantify the changes in HIV-related morbidity and mortality associated with the clinical use of antiretroviral therapy via prospectively collected patient-related events (admissions, bed days, deaths, WHO stage 3 and 4 events and drug costs) on all HIV patients known to the...

  • First-line Antiretroviral Therapy and Changes in Lipid Levels Over 3 Years Among HIV-Infected Adults in Tanzania. Liu, Enju; Armstrong, Catharina; Spiegelman, Donna; Chalamilla, Guerino; Njelekela, Marina; Hawkins, Claudia; Hertzmark, Ellen; Li, Nan; Aris, Eric; Muhihi, Alfa; Semu, Helen; Fawzi, Wafaie // Clinical Infectious Diseases;Jun2013, Vol. 56 Issue 12, p1820 

    In human immunodeficiency virus–infected Tanzanian adults, lipid abnormalities were improved temporarily then worsened gradually over a 3-year follow-up following antiretroviral therapy initiation, with more unfavorable changes in patients on stavudine- and efavirenz-based regimens...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics